Zheng Q. Toh

50 Flemington Road
Parkville, VIC 3052, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 70 publications

Targeted pneumococcal conjugate vaccination strategies for high-risk children.

Targeted pneumococcal conjugate vaccination strategies for high-risk children.

Journal: Human vaccines & immunotherapeutics

Published: June 03, 2026

Effect of time-of-day vaccination on the antibody response to mRNA and protein COVID-19 vaccine in adults.

Effect of time-of-day vaccination on the antibody response to mRNA and protein COVID-19 vaccine in adults.

Journal: Vaccine

Published: January 08, 2026

Cellular immune responses 12 months after fractional or standard dose BNT162b2 booster vaccination in Mongolian adults.

Cellular immune responses 12 months after fractional or standard dose BNT162b2 booster vaccination in Mongolian adults.

Journal: Frontiers in immunology

Published: January 02, 2026

Immunogenicity and efficacy over 12 months following a fourth dose of a bivalent mRNA or protein-based COVID-19 vaccine: A randomised controlled trial in Australia.

Immunogenicity and efficacy over 12 months following a fourth dose of a bivalent mRNA or protein-based COVID-19 vaccine: A randomised controlled trial in Australia.

Journal: The Journal of infection

Published: November 11, 2025

Immunogenicity of HPV Vaccine in a High-Risk and Understudied Group: Female Sex Workers.

Immunogenicity of HPV Vaccine in a High-Risk and Understudied Group: Female Sex Workers.

Journal: The Journal of infectious diseases

Published: October 30, 2025

Immunogenicity of Human Papillomavirus Virus Vaccine in a High-risk and Understudied Group: Female Sex Workers.

Immunogenicity of Human Papillomavirus Virus Vaccine in a High-risk and Understudied Group: Female Sex Workers.

Journal: The Journal of infectious diseases

Published: October 30, 2025

Serotype-specific immunity and association with pneumococcal carriage following 3+1, 3+0 and 2+1 schedules of 10-valent pneumococcal conjugate vaccine.

Serotype-specific immunity and association with pneumococcal carriage following 3+1, 3+0 and 2+1 schedules of 10-valent pneumococcal conjugate vaccine.

Journal: The Journal of infectious diseases

Published: October 23, 2025

Agreement Between Self-Reported COVID-19 and Dried Blood Spot Serology: A Cross-Sectional Study.

Agreement Between Self-Reported COVID-19 and Dried Blood Spot Serology: A Cross-Sectional Study.

Journal: Health science reports

Published: October 15, 2025

IgG Antibodies to Pneumococcal Serotypes 1 and 5 in Relation to PCV13 Vaccination Status in Children Aged Under 5 Years in Lao PDR: A Cross-Sectional Survey.

IgG Antibodies to Pneumococcal Serotypes 1 and 5 in Relation to PCV13 Vaccination Status in Children Aged Under 5 Years in Lao PDR: A Cross-Sectional Survey.

Journal: Vaccines

Published: June 11, 2025

Relationship between IL-17_A and pneumococcal carriage in children aged under two years: data from a randomised controlled trial in Vietnam.

Relationship between IL-17_A and pneumococcal carriage in children aged under two years: data from a randomised controlled trial in Vietnam.

Journal: Cytokine

Published: May 14, 2025

Differentiating Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Responses Between Infection and Vaccination: Challenges for Epidemiological Research.

Differentiating Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Responses Between Infection and Vaccination: Challenges for Epidemiological Research.

Journal: The Journal of infectious diseases

Published: April 16, 2025

The immunogenicity, reactogenicity, and safety of a bivalent mRNA or protein COVID-19 vaccine given as a fourth dose.

The immunogenicity, reactogenicity, and safety of a bivalent mRNA or protein COVID-19 vaccine given as a fourth dose.

Journal: The Journal of infection

Published: November 07, 2024

Showing 1-12 of 70

Last Updated: 09/26/2026